Intensivmedizinische Behandlung der thyreotoxischen Krise

• Literatur

• 1 Akamizu T et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 2012; 22: 661
• 2 Angell TE et al. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab 2015; 100: 451
• 3 Brooks MH, Waldstein SS. Free thyroxine concentrations in thyroid storm. Ann Intern Med 1980; 93: 694-697
• 4 Bilezikian JP et al. The influence of hyperthyroidism and hypothyroidism on the beta-adrenergic responsiveness of the turkey erythrocyte. J Clin Invest 1979; 63: 184-192
• 5 Braverman LE, Utiger RD eds. Wernerʼs and Ingbarʼs The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins; 2000: 679-684
• 6 Tunbridge WM et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-493
• 7 Golden SH et al. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009; 94: 1853-1878
• 8 Lederbogen S, Reinwein D. Epidemiologische Daten zur thyreotoxischen Krise, eine retrospektive Untersuchung. Akt Endokr Stoffw 1992; 13: 82-86
• 9 Swee duS et al. Clinical characteristics and outcome of thyroid storm: a case series and review of neuropsychiatric derangements in thyrotoxicosis. Endocr Pract 2015; 21: 182
• 10 Hehrmann R. Die thyreotoxische Krise: Fallstricke in der Diagnostik – Intensivtherapie. Fortschr Med 1996; 114: 26-31
• 11 Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet 2012; 379: 1155-1166
• 12 Sarlis NJ et al. Thyroid emergencies. Rev Endocr Metab Disord 2003; 4: 129
• 13 Karger S, Führer D. Thyreotoxische Krise – ein Update. Dtsch Med Wochenschr 2008; 133: 479-484
• 14 Nayak B et al. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am 2006; 35: 663
• 15 Gassanov N et al. Amiodaron-induzierte Schilddrüsenfunktionsstörungen. Dtsch Med Wochenschr 2010; 135: 807-811
• 16 Burch HB et al. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993; 22: 263
• 17 Gärtner R. Thyreotoxische Krise. In: Gärtner R, Hrsg. Schilddrüsenerkrankungen. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2004: 216-220
• 18 Watanabe N, Narimatsu H et al. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab 2012; 97: E49
• 19 FDA Drug Safety Communication. New Boxed Warning on severe liver injury with propylthiouracil. 2010 Im Internet: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm209023.htm [Stand: 22.04.2010]
• 20 Schwartz J, Winters JL, Padmanabhanet A et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue. Journal of Clinical Apheresis 2013; 28: 145-284
• 21 Tsatsoulis A, Johnson EO et al. The effect of thyrotoxicosis on adrenocortical reserve. Eur J Endocrinol 2000; 142: 231
• 22 Dralle H et al. Chirurgie der jodinduzierten Hyperthyreose. In: Reiners C. Schilddrüse 1997. Berlin: Walter De Gruyter; 1998: 310-318
• 23 Scholz GH et al. Is there a place for thyroidectomy in older patients with thyrotoxic storm and cardiorespiratory failure?. Thyroid 2003; 13: 933-940
• 24 Herrman J. Neuere Aspekte in der Therapie der thyreotoxischen Krise. Dtsch Med Wochenschr 1978; 103: 166-174